The ACCESS-CI project is supported by the Norwegian Research Council and the Bill & Melinda Gates Foundation and focuses on the removal of single-rod contraceptive implants.
The first in human investigations, the REVALID pilots, were performed at the WHO centre at Karolinska Hospital in 2016 and 2017. The device was found to be safe to use, and demonstrated sound proof of concept as an easy-to-use removal tool for contraceptive implants.
Feedback from the pilots was used to further improve device design and manufacture in preparation for the SAFE ACCESS trial to be conducted in Kampala, Uganda. The SAFE ACCESS trial is a randomized controlled trial comparing the device to the standard removal method, planning to recruit 225 subjects.
This project will target removal of 2-rod implants.